Recap: Intellia Therapeutics Q2 Earnings

 

Intellia Therapeutics NTLA reported its Q2 earnings results on Thursday, August 4, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Intellia Therapeutics missed estimated earnings by 1.53%, reporting an EPS of $-1.33 versus an estimate of $-1.31.

Revenue was up $7.48 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.86 which was followed by a 4.92% drop in the share price the next day.

Here's a look at Intellia Therapeutics's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -1.10 -0.94 -0.84 -0.63
EPS Actual -1.96 -1.09 -0.97 -1.01
Revenue Estimate 8.54M 8.26M 8.66M 11.89M
Revenue Actual 11.25M 12.85M 7.20M 6.55M

To track all earnings releases for Intellia Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...